CN111944000A - 5-Substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and synthesis method - Google Patents

5-Substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and synthesis method Download PDF

Info

Publication number
CN111944000A
CN111944000A CN202010961405.7A CN202010961405A CN111944000A CN 111944000 A CN111944000 A CN 111944000A CN 202010961405 A CN202010961405 A CN 202010961405A CN 111944000 A CN111944000 A CN 111944000A
Authority
CN
China
Prior art keywords
compound
reaction
anhydrous
synthesis
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202010961405.7A
Other languages
Chinese (zh)
Inventor
张晓辉
李若婕
李德鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University
Original Assignee
Dalian University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University filed Critical Dalian University
Priority to CN202010961405.7A priority Critical patent/CN111944000A/en
Publication of CN111944000A publication Critical patent/CN111944000A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

本发明属于合成化学领域,公开了一种5‑取代‑2,4‑二硫‑2’,3’‑O‑二叔丁基二甲硅烷基核苷化合物及合成方法。在氮气保护下,将5‑取代脱氧核苷化合物与叔丁基二甲基氯硅烷(TBSCl)反应,反应完成后进行后处理得化合物a;化合物a接着与1,2,4‑三唑溶解在无水乙腈溶剂中反应,得浅黄色固体b;最后化合物b与硫代乙酸在无水乙腈中反应,得到黄色固体化合物c;最后化合物c与劳森试剂(Lawesson's Reagent)在80℃无水甲苯中搅拌过夜,得到最终产物d。提供了一种5‑取代‑2,4‑二硫‑2’,3’‑O‑二叔丁基二甲硅烷基核苷化合物简便,高效,温和,后处理简单的合成方法。此合成方法具有在合成过程中避免使用毒性大的H2S气体和价格昂贵且保质期差的氯糖化合物等优势。The invention belongs to the field of synthetic chemistry, and discloses a 5-substituted-2,4-disulfide-2',3'-O-di-tert-butyldisilyl nucleoside compound and a synthesis method. Under nitrogen protection, the 5-substituted deoxynucleoside compound was reacted with tert-butyldimethylsilyl chloride (TBSCl), and after the reaction was completed, post-treatment was performed to obtain compound a; compound a was then dissolved with 1,2,4-triazole Reaction in anhydrous acetonitrile solvent to obtain light yellow solid b; finally compound b reacts with thioacetic acid in anhydrous acetonitrile to obtain yellow solid compound c; finally compound c and Lawesson's Reagent are anhydrous at 80°C Stir overnight in toluene to give final product d. Provided is a 5-substituted-2,4-disulfide-2',3'-O-di-tert-butyldisilyl nucleoside compound which is simple, efficient, mild and simple in post-processing. This synthesis method has the advantages of avoiding the use of toxic H 2 S gas and expensive chlorosaccharide compounds with poor shelf life in the synthesis process.

Description

5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物 及合成方法5-substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and synthesis method

技术领域technical field

本发明属于化学合成技术领域,本发明涉及一种5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物及其合成方法。The invention belongs to the technical field of chemical synthesis, and relates to a 5-substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and a synthesis method thereof.

背景技术Background technique

天然核苷是核糖或脱氧核糖和一个碱基(如腺嘌呤、胸腺嘧啶、鸟嘌呤、胞嘧啶或尿嘧啶)生成的糖苷,其为DNA和RNA的重要组成部分,在自然界的生命活动中起着不可替代的作用。自从Lipsett(Lipsett M N.The Journal of biological chemistry,1965,240(10).)从大肠杆菌分离出4-硫尿嘧啶核苷酸之后,含硫碱基和核苷便引起人们广泛的研究关注。Natural nucleosides are glycosides formed from ribose or deoxyribose and a base (such as adenine, thymine, guanine, cytosine or uracil), which are important components of DNA and RNA and play a role in life activities in nature. an irreplaceable role. Since Lipsett (Lipsett M N. The Journal of biological chemistry, 1965, 240 (10).) isolated 4-thiouracil nucleotides from Escherichia coli, thiobases and nucleosides have attracted extensive research attention .

与天然核苷酸相比,含有巯基的嘧啶环系列核苷化合物具有抗癌活性和免疫增强作用(NIGMN SC,SAHARA GS,SHAMM HR.Indian Chem Soc,1983,60:583-586.),另外有研究表明含有硫羰基的核苷类化合物其嘧啶碱基上4-位羰基氧被硫取代后吸光度变大,最大吸收峰红移,对光极其敏感(霍书华,李德鹏,王健,等.分子科学学报,2013,29(5):392-396.),使DNA分子对长波紫外线(UVA)或近紫外线光敏感。Compared with natural nucleotides, sulfhydryl-containing pyrimidine ring series nucleoside compounds have anticancer activity and immune enhancement (NIGMN SC, SAHARA GS, SHAMM HR. Indian Chem Soc, 1983, 60: 583-586.), in addition Studies have shown that nucleoside compounds containing a thiocarbonyl group have a large absorbance after the 4-position carbonyl oxygen on the pyrimidine base is replaced by sulfur, and the maximum absorption peak is red-shifted, which is extremely sensitive to light (Huo Shuhua, Li Depeng, Wang Jian, et al. Molecular Acta Scientifica, 2013, 29(5): 392-396.), making DNA molecules sensitive to long-wave ultraviolet (UVA) or near-ultraviolet light.

研究发现4-硫代核苷类似物对紫外线很敏感,可作为潜在抗肿瘤药物,尤其是与近紫外光(UVA)结合后可用于治疗皮肤癌(Pridgeon SW,Heer R,Taylor GABr.J.Cancer2011,104,1869.)。因此,徐耀忠和Karran等(Massey M,Xu YZ,Karran P.Curr.Biol.2011,11,1142)提出一种新的光化学治疗方法,即紫外光辅助4-硫胸苷疗法。该疗法利用硫代胸苷与天然胸苷结构相似,癌细胞在人体内快速自我复制增长的特点,将4-硫胸苷类似物并入癌变组织中,通过与特定波长UVA相互作用选择性损伤癌细胞的DNA,从而达到选择性杀死癌细胞,降低药物细胞毒性的目的。Studies have found that 4-thionucleoside analogs are sensitive to ultraviolet light and can be used as potential antitumor drugs, especially when combined with near ultraviolet light (UVA) for the treatment of skin cancer (Pridgeon SW, Heer R, Taylor GABr.J. Cancer 2011, 104, 1869.). Therefore, Xu Yaozhong and Karran et al. (Massey M, Xu YZ, Karran P.Curr.Biol.2011,11,1142) proposed a new photochemotherapy method, namely ultraviolet light-assisted 4-thiothymidine therapy. This therapy utilizes the similar structure of thiothymidine to natural thymidine, the rapid self-replication and growth of cancer cells in the human body, and incorporates 4-thiothymidine analogs into cancerous tissues, selectively damaging by interacting with UVA of specific wavelengths DNA of cancer cells, so as to selectively kill cancer cells and reduce the cytotoxicity of drugs.

由于UVA的组织穿透能力有限,因此S4TdR/UVA疗法对一些距离皮表较近的实体器官的恶性肿瘤是有效的,例如皮表、泌尿道、消化道、上呼吸道等。对于一些UVA无法进入的实体器官的恶性肿瘤,此疗法可能无法很好发挥作用,例如肺、脑、肝、肾。Due to the limited tissue penetration ability of UVA, S 4 TdR/UVA therapy is effective for malignant tumors of some solid organs close to the skin surface, such as the skin surface, urinary tract, digestive tract, upper respiratory tract, etc. This therapy may not work well for some malignancies of solid organs that UVA cannot access, such as lung, brain, liver, kidney.

因此为解决这一问题,以4-硫脱氧胸苷为基础,进行新的结构修饰和取代,使硫代化合物的吸收波长向可见光区发展,在临床上配合光导纤维的发展,意味着今后此疗法也可应用在深源性的肿瘤治疗上。Therefore, in order to solve this problem, based on 4-thiodeoxythymidine, new structural modifications and substitutions were carried out to make the absorption wavelength of the thio compounds develop to the visible light region. The therapy can also be applied to the treatment of deep-derived tumors.

Marvin Pollum提出2,4-二硫代胸腺嘧啶的最大吸收波长在363nm处(Pollum M,Jockusch S,Crespo-Hernandez CE.J Am Chem Soc.2014;136(52):17930-3.),这为实现硫代化合物的吸收波长向可见光区发展提供了理论基础。但对于双硫化合物的合成方法鲜有文献报道,因此对此类含硫类核苷衍生物的开发和合成方法的研究具有重要意义。Marvin Pollum proposed that the maximum absorption wavelength of 2,4-dithiothymine is at 363 nm (Pollum M, Jockusch S, Crespo-Hernandez CE. J Am Chem Soc. 2014; 136(52): 17930-3.), which It provides a theoretical basis for realizing the development of the absorption wavelength of thio compounds to the visible light region. However, there are few literature reports on the synthesis of disulfide compounds, so the research on the development and synthesis of such sulfur-containing nucleoside derivatives is of great significance.

发明内容SUMMARY OF THE INVENTION

为了克服现有技术的不足,本发明提供一种5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物及其合成方法。该合成方法简便,高效,温和,后处理简单。In order to overcome the deficiencies of the prior art, the present invention provides a 5-substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and a synthesis method thereof. The synthesis method is simple, efficient, mild and simple in post-processing.

本发明的上述目的是通过以下技术方案实现的:Above-mentioned purpose of the present invention is achieved through the following technical solutions:

一种5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物;具有通式(d)结构:A 5-substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound; has the structure of general formula (d):

Figure BDA0002680682550000031
Figure BDA0002680682550000031

其中,X=CH3、H、F、Cl、Br、I。Wherein, X=CH 3 , H, F, Cl, Br, I.

5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物的具体结构式如下:The specific structural formula of the 5-substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound is as follows:

Figure BDA0002680682550000032
Figure BDA0002680682550000032

其中A为脱氧胸苷,B为脱氧尿苷,C为5-氟脱氧核苷,D为5-氯脱氧核苷,E为5-溴脱氧核苷,F为5-碘脱氧核苷。。Wherein A is deoxythymidine, B is deoxyuridine, C is 5-fluorodeoxynucleoside, D is 5-chlorodeoxynucleoside, E is 5-bromodeoxynucleoside, and F is 5-iododeoxynucleoside. .

一种5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物及其合成方法;以脱氧核苷为原料,以劳森试剂为硫化剂,在无水甲苯溶剂中发生化学反应,最终得到通式d所示化合物;A 5-substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and a method for synthesizing the same; using deoxynucleoside as raw material, using Lawson's reagent as sulfur agent, chemical reaction takes place in anhydrous toluene solvent, and finally the compound shown in general formula d is obtained;

Figure BDA0002680682550000041
Figure BDA0002680682550000041

其中,X=H、CH3、F、Cl、Br、I。Wherein, X=H, CH 3 , F, Cl, Br, I.

进一步的,上述5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物合成方法步骤为:在氮气保护下,将5-取代脱氧核苷化合物与叔丁基二甲基氯硅烷(TBSCl)反应,反应完成后进行后处理得化合物a;化合物a接着与1,2,4-三唑溶解在无水乙腈溶剂中反应,得浅黄色固体b;最后化合物b与硫代乙酸在无水乙腈中反应,得到黄色固体化合物c;最后化合物c与劳森试剂(Lawesson's Reagent)在80℃无水甲苯中搅拌过夜,得到最终产物d。Further, the above-mentioned 5-substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound synthesis method steps are: under the protection of nitrogen, 5-substituted deoxynucleoside The glycoside compound is reacted with tert-butyldimethylsilyl chloride (TBSCl), and after the reaction is completed, post-treatment is performed to obtain compound a; compound a is then reacted with 1,2,4-triazole dissolved in anhydrous acetonitrile solvent to obtain light yellow solid b; finally compound b reacted with thioacetic acid in anhydrous acetonitrile to obtain yellow solid compound c; finally compound c and Lawesson's Reagent were stirred overnight in anhydrous toluene at 80°C to obtain final product d.

进一步的,上述5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物合成方法具体步骤为:Further, the specific steps of the above-mentioned 5-substituted-2,4-disulfide-2',3'-O-di-tert-butyldisilyl nucleoside compound synthesis method are:

S1.化合物a的合成:在氮气保护下,将1当量5-取代脱氧核苷化合物和3当量咪唑溶解在二氯甲烷中,冰水浴下(0℃)搅拌30分钟;30分钟后,向反应体系中加入2.5当量叔丁基二甲基氯硅烷(TBSCl),室温搅拌1小时;TLC检测反应结束后,用水进行猝灭,二氯甲烷萃取;合并有机相,用饱和NaCl洗涤,无水NaSO4干燥,过滤,减压蒸去溶剂,得化合物a,为白色固体,无须纯化直接进行下一步S2;S1. Synthesis of compound a: under nitrogen protection, dissolve 1 equivalent of 5-substituted deoxynucleoside compound and 3 equivalents of imidazole in dichloromethane, and stir under an ice-water bath (0°C) for 30 minutes; after 30 minutes, add the reaction 2.5 equivalents of tert-butyldimethylsilyl chloride (TBSCl) was added to the system, and stirred at room temperature for 1 hour; after the reaction was detected by TLC, quenched with water and extracted with dichloromethane; the organic phases were combined, washed with saturated NaCl, and anhydrous NaSO 4. Dry, filter, and evaporate the solvent under reduced pressure to obtain compound a as a white solid, and proceed directly to the next step S2 without purification;

S2.化合物b的合成:将14当量的1,2,4-三唑溶解在无水乙腈中,冰水浴(0℃)搅拌下缓慢加入三氯氧磷,三乙胺;反应1小时后,投入上述S1制备的1当量白色固体化合物a,室温下搅拌过夜;TLC检测反应结束后,将反应液过滤,有机相用二氯甲烷稀释,饱和NaHCO3溶液洗涤,饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤,减压蒸去溶剂,得化合物b,为浅黄色固体,无须纯化直接进行下一步S3;S2. Synthesis of compound b: dissolve 14 equivalents of 1,2,4-triazole in anhydrous acetonitrile, slowly add phosphorus oxychloride and triethylamine under stirring in an ice-water bath (0°C); after 1 hour of reaction, 1 equivalent of white solid compound a prepared by the above-mentioned S1 was added, and stirred overnight at room temperature; after the reaction was detected by TLC, the reaction solution was filtered, the organic phase was diluted with dichloromethane, washed with saturated NaHCO solution, washed with saturated NaCl solution, and washed with anhydrous Na 2 Dry over SO 4 , filter, and evaporate the solvent under reduced pressure to obtain compound b as a light yellow solid, and proceed directly to the next step S3 without purification;

S3.化合物c的合成:将1当量的化合物b溶解在无水乙腈中,加入14当量的硫代乙酸,室温下搅拌过夜;TLC检测反应结束后,反应液用二氯甲烷稀释,饱和NaHCO3溶液洗涤,饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤,减压蒸去溶剂,得到黄色固体,硅胶柱分离纯化,得到化合物c;S3. Synthesis of compound c: dissolve 1 equivalent of compound b in anhydrous acetonitrile, add 14 equivalents of thioacetic acid, and stir overnight at room temperature; after TLC detects the reaction, the reaction solution is diluted with dichloromethane, saturated NaHCO 3 The solution was washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered, and the solvent was evaporated under reduced pressure to obtain a yellow solid, which was separated and purified on a silica gel column to obtain compound c;

S4.化合物d的合成:将1当量的化合物c溶解在无水甲苯中,加入2当量的劳森试剂(Lawesson's Reagent),80℃下搅拌过夜。硅胶柱分离纯化,得到化合物d,为黄色固体。S4. Synthesis of compound d: dissolve 1 equivalent of compound c in anhydrous toluene, add 2 equivalents of Lawesson's Reagent, and stir at 80°C overnight. Silica gel column separation and purification to obtain compound d as a yellow solid.

进一步的,步骤S4中化合物c在无水甲苯反应的温度为80℃。Further, in step S4, the reaction temperature of compound c in anhydrous toluene is 80°C.

本发明与现有技术相比的有益效果是:The beneficial effects of the present invention compared with the prior art are:

本发明为制备此类5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物提供了一种合成方法。在从化合物(b)-(d)的合成中,首先通过利用三唑硫化脱氧核苷达到在脱氧核苷化合物4位上硫的目的,继而利用劳森试剂在4-硫脱氧核苷化合物2位上S原子,通过改变对脱氧核苷化合物的上硫顺序,以及运用两种硫化试剂,分别为硫代乙酸和劳森试剂,实现了合成5-取代-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基核苷化合物的目的。此合成方法具有条件温和、环境污染小、收率高、易分离纯化等优势,在合成过程中避免了使用易燃易爆且毒性大的H2S气体,避免了通过H2S气体先合成2-硫脱氧核苷再合成2,4-二硫脱氧核苷且产率低、构型变化的繁琐手段,避免使用价格昂贵且保质期差的氯糖化合物等。The invention provides a synthetic method for preparing such 5-substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compounds. In the synthesis of compounds (b)-(d), firstly, the purpose of sulfur at the 4-position of the deoxynucleoside compound is achieved by using triazole to sulfide the deoxynucleoside compound, and then the 4-thiodeoxynucleoside compound 2 is obtained by using Lawesson's reagent. On the S atom, the synthesis of 5-substituted-2,4-disulfide-2' was achieved by changing the order of sulfur addition to deoxynucleoside compounds and using two sulfurizing reagents, thioacetic acid and Lawson's reagent, respectively. , The purpose of 3'-O-di-tert-butyldisilyl nucleoside compounds. This synthesis method has the advantages of mild conditions, low environmental pollution, high yield, easy separation and purification, etc. In the synthesis process, the use of flammable, explosive and highly toxic H 2 S gas is avoided, and the first synthesis of H 2 S gas is avoided. 2-thiodeoxynucleoside is a cumbersome method for resynthesizing 2,4-dithiodeoxynucleoside with low yield and configuration change, avoiding the use of expensive chlorosugar compounds with poor shelf life.

附图说明Description of drawings

图1为本发明实施例1的化合物a1的核磁表征图谱。Fig. 1 is the nuclear magnetic characterization spectrum of compound a1 of Example 1 of the present invention.

图2为本发明实施例1的化合物b1的核磁表征图谱。FIG. 2 is the NMR characterization spectrum of compound b1 of Example 1 of the present invention.

图3为本发明实施例1的化合物c1的核磁表征图谱。Fig. 3 is the nuclear magnetic characterization spectrum of compound c1 of Example 1 of the present invention.

图4为本发明实施例1的化合物d1的核磁表征图谱。FIG. 4 is the nuclear magnetic characterization spectrum of compound d1 of Example 1 of the present invention.

具体实施方式Detailed ways

下面通过具体实施例详述本发明,但不限制本发明的保护范围。如无特殊说明,本发明所采用的实验方法均为常规方法,所用实验器材、材料、试剂等均可从商业途径获得。The present invention is described in detail below through specific embodiments, but the protection scope of the present invention is not limited. Unless otherwise specified, the experimental methods used in the present invention are all conventional methods, and the experimental equipment, materials, reagents, etc. used can be obtained from commercial sources.

实施例1Example 1

2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基脱氧胸苷,其结构式为通式d1所示,2,4-Dithio-2',3'-O-di-tert-butyldimethylsilyldeoxythymidine, whose structural formula is shown in general formula d 1 ,

Figure BDA0002680682550000061
Figure BDA0002680682550000061

S1.化合物a1的合成:在氮气保护下,将脱氧胸苷(3g)和咪唑(2.52g)溶解在二氯甲烷(20ml)中,冰水浴下搅拌30分钟。30分钟后,向反应体系中加入叔丁基二甲基氯硅烷(TBSCl)(4.65g),室温搅拌1小时。TLC检测反应结束后,用水进行猝灭,二氯甲烷萃取。合并有机相,用饱和NaCl洗涤,无水NaSO4干燥,过滤,减压蒸去溶剂,得化合物a1,为白色固体,5.8g,产率99%,无须纯化直接进行下一步S2。1H NMR(CDCl3,500MHz)δ:8.11(s,1H),7.48(s,1H),6.34(t,J=6.7Hz,1H),4.42–4.36(m,1H),3.95–3.72(m,3H),2.27–2.19(m,1H),2.05–1.96(m,1H),1.92(s,3H),0.91(d,J=17.9Hz,18H),0.14–0.04(m,12H)。S1. Synthesis of compound a1: Under nitrogen protection, deoxythymidine (3 g) and imidazole (2.52 g) were dissolved in dichloromethane (20 ml), and stirred for 30 minutes in an ice-water bath. After 30 minutes, tert-butyldimethylsilyl chloride (TBSCl) (4.65 g) was added to the reaction system, and the mixture was stirred at room temperature for 1 hour. After TLC detection, the reaction was quenched with water and extracted with dichloromethane. The organic phases were combined, washed with saturated NaCl, dried over anhydrous NaSO 4 , filtered, and the solvent was evaporated under reduced pressure to obtain compound a 1 as a white solid, 5.8 g, yield 99%, directly proceed to the next step S2 without purification. 1 H NMR (CDCl 3 , 500MHz) δ: 8.11 (s, 1H), 7.48 (s, 1H), 6.34 (t, J=6.7 Hz, 1H), 4.42-4.36 (m, 1H), 3.95-3.72 ( m, 3H), 2.27–2.19 (m, 1H), 2.05–1.96 (m, 1H), 1.92 (s, 3H), 0.91 (d, J=17.9Hz, 18H), 0.14–0.04 (m, 12H) .

S2.化合物b1的合成:将1,2,4-三唑(10.22g)溶解在无水乙腈(120ml)中,冰水浴搅拌下缓慢加入三氯氧磷(3.192ml),三乙胺(24ml)。反应1小时后,投入上述S1制备的化合物a1白色固体(5g),室温下搅拌过夜。TLC检测反应结束后,将反应液过滤,有机相用二氯甲烷稀释,饱和NaHCO3溶液洗涤,饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤,减压蒸去溶剂,得化合物b1,为浅黄色固体,5.16g,产率99%,无须纯化直接进行下一步S3。1H NMR(CDCl3,500MHz)δ:9.28(s,1H),8.25(s,1H),8.11(s,1H),6.29(t,J=6.2Hz,1H),4.39(s,1H),4.06(s,1H),3.88(dd,J=83.3,11.5Hz,3H),2.67–2.54(m,1H),2.44(s,3H),2.08(dd,J=13.3,6.5Hz,1H),0.90(d,J=7.9Hz,18H),0.09(dd,J=17.8,6.5Hz,12H)。S2. Synthesis of compound b 1 : Dissolve 1,2,4-triazole (10.22g) in anhydrous acetonitrile (120ml), slowly add phosphorus oxychloride (3.192ml), triethylamine ( 24ml). After the reaction for 1 hour, the white solid (5 g) of compound a1 prepared in the above S1 was added, and the mixture was stirred at room temperature overnight. After the reaction was detected by TLC, the reaction solution was filtered, the organic phase was diluted with dichloromethane, washed with saturated NaHCO 3 solution, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered, and the solvent was evaporated under reduced pressure to obtain compound b 1 , was a light yellow solid, 5.16 g, the yield was 99%, directly proceeded to the next step S3 without purification. 1 H NMR (CDCl 3 , 500MHz) δ: 9.28(s, 1H), 8.25(s, 1H), 8.11(s, 1H), 6.29(t, J=6.2Hz, 1H), 4.39(s, 1H) ,4.06(s,1H),3.88(dd,J=83.3,11.5Hz,3H),2.67–2.54(m,1H),2.44(s,3H),2.08(dd,J=13.3,6.5Hz,1H ), 0.90 (d, J=7.9Hz, 18H), 0.09 (dd, J=17.8, 6.5Hz, 12H).

S3.化合物c1的合成:将化合物b1(5g)溶解在无水乙腈(191ml)中,加入硫代乙酸(9.6ml),室温下搅拌过夜。TLC检测反应结束后,反应液用二氯甲烷稀释,饱和NaHCO 3溶液洗涤,饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤,减压蒸去溶剂,得到黄色固体,硅胶柱分离纯化,得到化合物c1,3.74g,产率80%。1H NMR(CDCl3,500MHz)δ:9.39(s,1H),7.51(s,1H),6.21(t,J=6.7Hz,1H),4.34(s,1H),3.91(s,1H),3.86–3.65(m,2H),2.29–2.20(m,1H),2.04(s,3H),1.95(dt,J=13.2,6.8Hz,1H),0.85(d,J=15.1Hz,18H),0.04(d,J=15.7Hz,12H)。S3. Synthesis of compound c 1 : Compound b 1 (5 g) was dissolved in anhydrous acetonitrile (191 ml), thioacetic acid (9.6 ml) was added, and the mixture was stirred at room temperature overnight. After the reaction was detected by TLC, the reaction solution was diluted with dichloromethane, washed with saturated NaHCO 3 solution, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered, and the solvent was evaporated under reduced pressure to obtain a yellow solid, which was separated and purified on a silica gel column. Compound c 1 was obtained, 3.74 g in 80% yield. 1 H NMR (CDCl 3 , 500MHz) δ: 9.39(s, 1H), 7.51(s, 1H), 6.21(t, J=6.7Hz, 1H), 4.34(s, 1H), 3.91(s, 1H) ,3.86–3.65(m,2H),2.29–2.20(m,1H),2.04(s,3H),1.95(dt,J=13.2,6.8Hz,1H),0.85(d,J=15.1Hz,18H ), 0.04 (d, J=15.7Hz, 12H).

S4.化合物4的合成:将化合物c1(2g)溶解在无水甲苯(17ml)中,加入劳森试剂(Lawesson's Reagent)(3.32g),80℃下搅拌过夜。硅胶柱分离纯化,得到化合物d1,为黄色固体,1.13g,产率55%。1H NMR(CDCl3,500MHz)δ:10.62(s,1H),7.73(s,1H),6.74(t,J=6.3Hz,1H),4.38(s,1H),4.05–3.73(m,3H),2.56(dt,J=13.2,4.3Hz,1H),2.12(s,3H),1.97(dt,J=13.2,6.7Hz,1H),0.91(d,J=10.3Hz,18H),0.12(d,J=4.1Hz,6H),0.09(d,J=8.4Hz,6H).S4. Synthesis of compound 4: Compound c 1 (2 g) was dissolved in anhydrous toluene (17 ml), Lawesson's Reagent (3.32 g) was added, and the mixture was stirred at 80° C. overnight. Silica gel column separation and purification to obtain compound d 1 as a yellow solid, 1.13 g, yield 55%. 1 H NMR (CDCl 3 , 500MHz) δ: 10.62(s, 1H), 7.73(s, 1H), 6.74(t, J=6.3Hz, 1H), 4.38(s, 1H), 4.05-3.73(m, 3H), 2.56(dt, J=13.2, 4.3Hz, 1H), 2.12(s, 3H), 1.97(dt, J=13.2, 6.7Hz, 1H), 0.91(d, J=10.3Hz, 18H), 0.12(d,J=4.1Hz,6H),0.09(d,J=8.4Hz,6H).

实施例2Example 2

2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基脱氧尿苷;其结构式为通式d2所示,2,4-Dithio-2',3'-O-di-tert-butyldisilyldeoxyuridine; its structural formula is shown in general formula d 2 ,

Figure BDA0002680682550000081
Figure BDA0002680682550000081

S1.化合物a2的合成:在氮气保护下,将脱氧尿苷(5g)和咪唑(4.49g)溶解在二氯甲烷(34ml)中,冰水浴下搅拌30分钟。30分钟后,向反应体系中加入叔丁基二甲基氯硅烷(TBSCl)(8.3g),室温搅拌1小时。TLC检测反应结束后,用水进行猝灭,二氯甲烷萃取。合并有机相,用饱和NaCl洗涤,无水NaSO4干燥,过滤,减压蒸去溶剂,得化合物a2,为白色固体,9.9g,产率99%,无须纯化直接进行下一步S2。1H NMR(CDCl3,500MHz)δ:8.72(s,1H),7.95–7.87(m,1H),6.30(t,J=6.1Hz,1H),5.69(d,J=8.1Hz,1H),4.41(dd,J=6.0,3.6Hz,1H),3.83(dd,J=73.6,11.5Hz,3H),2.32(dt,J=10.8,5.0Hz,1H),2.07(dt,J=12.7,5.8Hz,1H),0.91(d,J=15.0Hz,18H),0.09(d,J=15.3Hz,12H)。S1. Synthesis of compound a 2 : Under nitrogen protection, deoxyuridine (5 g) and imidazole (4.49 g) were dissolved in dichloromethane (34 ml), and stirred for 30 minutes in an ice-water bath. After 30 minutes, tert-butyldimethylsilyl chloride (TBSCl) (8.3 g) was added to the reaction system, followed by stirring at room temperature for 1 hour. After TLC detection, the reaction was quenched with water and extracted with dichloromethane. The organic phases were combined, washed with saturated NaCl, dried over anhydrous NaSO 4 , filtered, and the solvent was evaporated under reduced pressure to obtain compound a 2 as a white solid, 9.9 g, yield 99%, directly proceed to the next step S2 without purification. 1 H NMR (CDCl 3 , 500MHz) δ: 8.72 (s, 1H), 7.95-7.87 (m, 1H), 6.30 (t, J=6.1 Hz, 1H), 5.69 (d, J=8.1 Hz, 1H) ,4.41(dd,J=6.0,3.6Hz,1H),3.83(dd,J=73.6,11.5Hz,3H),2.32(dt,J=10.8,5.0Hz,1H),2.07(dt,J=12.7 , 5.8Hz, 1H), 0.91 (d, J=15.0Hz, 18H), 0.09 (d, J=15.3Hz, 12H).

S2.化合物b2的合成:将1,2,4-三唑(6.7g)溶解在无水乙腈中,冰水浴搅拌下缓慢加入三氯氧磷(2.1ml),三乙胺(15.8ml)。反应1小时后,投入上述S1制备的化合物a2白色固体(3g),室温下搅拌过夜。TLC检测反应结束后,将反应液过滤,有机相用二氯甲烷稀释,饱和NaHCO3溶液洗涤,饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤,减压蒸去溶剂,得化合物b2,为浅黄色固体,3.3g,产率99%,无须纯化直接进行下一步S3。S2. Synthesis of compound b 2 : 1,2,4-triazole (6.7g) was dissolved in anhydrous acetonitrile, and phosphorus oxychloride (2.1ml) and triethylamine (15.8ml) were slowly added under stirring in an ice-water bath. . After 1 hour of reaction, the compound a2 prepared in the above S1 was put into white solid ( 3 g), and the mixture was stirred at room temperature overnight. After the reaction was detected by TLC, the reaction solution was filtered, the organic phase was diluted with dichloromethane, washed with saturated NaHCO 3 solution, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered, and the solvent was evaporated under reduced pressure to obtain compound b 2 , was a light yellow solid, 3.3 g, the yield was 99%, directly proceeded to the next step S3 without purification.

S3.化合物c2的合成:将化合物b2(3g)溶解在无水乙腈中,加入硫代乙酸(5.9ml,室温下搅拌过夜。TLC检测反应结束后,反应液用二氯甲烷稀释,饱和NaHCO3溶液洗涤,饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤,减压蒸去溶剂,得到黄色固体,硅胶柱分离纯化,得到化合物c2,2.17g,产率78%。1H NMR(CDCl3,500MHz)δ:9.58(s,1H),7.81(s,1H),6.42–6.32(m,1H),6.23(q,J=6.0,4.3Hz,1H),3.96–3.71(m,3H),2.52(d,J=4.7Hz,1H),2.35(h,J=4.8Hz,1H),2.12–2.03(m,1H),0.90(d,J=15.6Hz,18H),0.09(d,J=13.9Hz,12H)。S3. Synthesis of compound c 2 : Compound b 2 (3 g) was dissolved in anhydrous acetonitrile, thioacetic acid (5.9 ml) was added, and stirred overnight at room temperature. After TLC detected the reaction, the reaction solution was diluted with dichloromethane, saturated with Washed with NaHCO 3 solution, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered, and evaporated the solvent under reduced pressure to obtain a yellow solid, which was separated and purified by silica gel column to obtain compound c 2 , 2.17 g, yield 78%. 1 H NMR (CDCl 3 , 500MHz) δ: 9.58 (s, 1H), 7.81 (s, 1H), 6.42-6.32 (m, 1H), 6.23 (q, J=6.0, 4.3Hz, 1H), 3.96-3.71 ( m, 3H), 2.52 (d, J=4.7Hz, 1H), 2.35 (h, J=4.8Hz, 1H), 2.12–2.03 (m, 1H), 0.90 (d, J=15.6Hz, 18H), 0.09 (d, J=13.9 Hz, 12H).

S4.化合物d2的合成:将化合物c2(2g)溶解在无水甲苯(17ml)中,加入劳森试剂(Lawesson's Reagent)(3.4g),80℃下搅拌过夜。硅胶柱分离纯化,得到化合物d2,为黄色固体,1.027g,产率50%。S4. Synthesis of compound d 2 : Compound c 2 (2 g) was dissolved in anhydrous toluene (17 ml), Lawesson's Reagent (3.4 g) was added, and the mixture was stirred at 80° C. overnight. Silica gel column separation and purification to obtain compound d 2 as a yellow solid, 1.027 g, yield 50%.

实施例3Example 3

5-F-2,4-二硫-2’,3’-O-二叔丁基二甲硅烷基脱氧尿苷;其结构式为通式d3所示,5-F-2,4-dithio-2',3'-O-di-tert-butyldimethylsilyldeoxyuridine; its structural formula is shown in general formula d 3 ,

Figure BDA0002680682550000101
Figure BDA0002680682550000101

S1.化合物a3的合成:在氮气保护下,将脱氧胸苷(5g)和咪唑(4.15g)溶解在二氯甲烷(34ml)中,冰水浴下搅拌30分钟。30分钟后,向反应体系中加入叔丁基二甲基氯硅烷(TBSCl)(7.65g),室温搅拌1小时。TLC检测反应结束后,用水进行猝灭,二氯甲烷萃取。合并有机相,用饱和NaCl洗涤,无水NaSO4干燥,过滤,减压蒸去溶剂,得化合物a3,为白色固体,9.54g,产率99%,无须纯化直接进行下一步S2。1H NMR(CDCl3,500MHz)δ:8.62(s,1H),8.07(d,J=6.2Hz,1H),6.30(t,J=6.0Hz,1H),4.41(dt,J=6.2,3.1Hz,1H),3.94(d,J=12.5Hz,2H),3.77(d,J=11.1Hz,1H),2.32(ddd,J=13.2,6.1,3.5Hz,1H),2.06(p,J=6.3Hz,1H),0.91(d,J=19.1Hz,18H),0.11(dd,J=24.6,2.9Hz,12H)。S1. Synthesis of compound a 3 : Under nitrogen protection, deoxythymidine (5 g) and imidazole (4.15 g) were dissolved in dichloromethane (34 ml), and stirred for 30 minutes in an ice-water bath. After 30 minutes, tert-butyldimethylsilyl chloride (TBSCl) (7.65 g) was added to the reaction system, followed by stirring at room temperature for 1 hour. After TLC detection, the reaction was quenched with water and extracted with dichloromethane. The organic phases were combined, washed with saturated NaCl, dried over anhydrous NaSO 4 , filtered, and the solvent was evaporated under reduced pressure to obtain compound a 3 as a white solid, 9.54 g, yield 99%, directly proceed to the next step S2 without purification. 1 H NMR (CDCl 3 , 500 MHz) δ: 8.62 (s, 1H), 8.07 (d, J=6.2 Hz, 1H), 6.30 (t, J=6.0 Hz, 1H), 4.41 (dt, J=6.2, 3.1Hz, 1H), 3.94 (d, J=12.5Hz, 2H), 3.77 (d, J=11.1Hz, 1H), 2.32 (ddd, J=13.2, 6.1, 3.5Hz, 1H), 2.06 (p, J=6.3Hz, 1H), 0.91 (d, J=19.1Hz, 18H), 0.11 (dd, J=24.6, 2.9Hz, 12H).

S2.化合物b3的合成:将1,2,4-三唑(6.44g)溶解在无水乙腈(41.05ml)中,冰水浴搅拌下缓慢加入三氯氧磷(153.33ml),三乙胺(101.19ml)。反应1小时后,投入上述S1制备的化合物a3白色固体(3g),室温下搅拌过夜。TLC检测反应结束后,将反应液过滤,有机相用二氯甲烷稀释,饱和NaHCO3溶液洗涤,饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤,减压蒸去溶剂,得化合物b3,为浅黄色固体,3.28g,产率99%,无须纯化直接进行下一步S3。1H NMR(CDCl3,500MHz)δ:9.26(s,1H),8.86(d,J=6.0Hz,1H),8.22(s,1H),6.23(d,J=5.3Hz,1H),4.41(d,J=4.8Hz,1H),4.15–3.97(m,3H),3.83(d,J=11.5Hz,1H),2.61(dq,J=13.2,6.3,5.2Hz,1H),2.23(dt,J=13.5,5.0Hz,1H),2.05(s,0H),0.94(s,9H),0.89(s,9H),0.15(d,J=9.9Hz,6H),0.08(s,6H)。S2. Synthesis of compound b 3 : 1,2,4-triazole (6.44g) was dissolved in anhydrous acetonitrile (41.05ml), phosphorus oxychloride (153.33ml) was slowly added under stirring in an ice-water bath, triethylamine (101.19ml). After 1 hour of reaction, the compound a3 prepared in the above S1 was put into white solid ( 3 g), and the mixture was stirred at room temperature overnight. After the reaction was detected by TLC, the reaction solution was filtered, the organic phase was diluted with dichloromethane, washed with saturated NaHCO 3 solution, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered, and the solvent was evaporated under reduced pressure to obtain compound b 3 , was a light yellow solid, 3.28 g, the yield was 99%, directly proceeded to the next step S3 without purification. 1 H NMR (CDCl3, 500MHz)δ: 9.26(s, 1H), 8.86(d, J=6.0Hz, 1H), 8.22(s, 1H), 6.23(d, J=5.3Hz, 1H), 4.41( d, J=4.8Hz, 1H), 4.15–3.97 (m, 3H), 3.83 (d, J=11.5Hz, 1H), 2.61 (dq, J=13.2, 6.3, 5.2Hz, 1H), 2.23 (dt , J=13.5, 5.0Hz, 1H), 2.05(s, 0H), 0.94(s, 9H), 0.89(s, 9H), 0.15(d, J=9.9Hz, 6H), 0.08(s, 6H) .

S3.化合物c3的合成:将化合物b3(3g)溶解在无水乙腈(115ml)中,加入硫代乙酸(5.7ml),室温下搅拌过夜。TLC检测反应结束后,反应液用二氯甲烷稀释,饱和NaHCO3溶液洗涤,饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤,减压蒸去溶剂,得到黄色固体,硅胶柱分离纯化,得到化合物c3,2.26g,产率81%。1H NMR(CDCl3,500MHz)δ:9.50(s,1H),8.05(d,J=3.9Hz,1H),6.23(d,J=5.4Hz,1H),4.42(s,1H),3.99–3.66(m,3H),2.39–2.24(m,1H),2.09(dt,J=12.9,5.7Hz,1H),0.91(d,J=18.8Hz,18H),0.17–-0.00(m,12H)。S3. Synthesis of compound c 3 : Compound b 3 (3 g) was dissolved in anhydrous acetonitrile (115 ml), thioacetic acid (5.7 ml) was added, and the mixture was stirred at room temperature overnight. After the reaction was detected by TLC, the reaction solution was diluted with dichloromethane, washed with saturated NaHCO 3 solution, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered, and the solvent was evaporated under reduced pressure to obtain a yellow solid, which was separated and purified on a silica gel column. Compound c 3 was obtained, 2.26 g in 81% yield. 1 H NMR (CDCl 3 , 500MHz) δ: 9.50 (s, 1H), 8.05 (d, J=3.9 Hz, 1H), 6.23 (d, J=5.4 Hz, 1H), 4.42 (s, 1H), 3.99 –3.66(m,3H),2.39–2.24(m,1H),2.09(dt,J=12.9,5.7Hz,1H),0.91(d,J=18.8Hz,18H),0.17–-0.00(m, 12H).

S4.化合物d3的合成:将化合物c3(2g)溶解在无水甲苯(16ml)中,加入劳森试剂(Lawesson's Reagent)(3.23g),80℃下搅拌过夜。硅胶柱分离纯化,得到化合物d3,为黄色固体,1.054g,产率52%。1H NMR(CDCl3,500MHz)δ:10.52(s,1H),8.23(d,J=3.7Hz,1H),6.61(t,J=5.3Hz,1H),4.40(t,J=5.3Hz,1H),4.06–3.78(m,3H),2.54(dt,J=13.1,6.1Hz,1H),2.15(dq,J=13.7,5.7,4.5Hz,1H),0.93(s,9H),0.89(s,9H),0.11(dd,J=23.3,5.7Hz,12H)。S4. Synthesis of compound d 3 : Compound c 3 (2 g) was dissolved in anhydrous toluene (16 ml), Lawesson's Reagent (3.23 g) was added, and the mixture was stirred at 80° C. overnight. Silica gel column separation and purification to obtain compound d 3 as a yellow solid, 1.054 g, yield 52%. 1 H NMR (CDCl 3 , 500MHz) δ: 10.52 (s, 1H), 8.23 (d, J=3.7Hz, 1H), 6.61 (t, J=5.3Hz, 1H), 4.40 (t, J=5.3Hz) ,1H),4.06–3.78(m,3H),2.54(dt,J=13.1,6.1Hz,1H),2.15(dq,J=13.7,5.7,4.5Hz,1H),0.93(s,9H), 0.89 (s, 9H), 0.11 (dd, J=23.3, 5.7Hz, 12H).

以上所述实施方式仅为本发明的优选实施例,而并非本发明可行实施的全部实施例。对于本领域一般技术人员而言,在不背离本发明原理和精神的前提下对其所作出的任何显而易见的改动,都应当被认为包含在本发明的权利要求保护范围之内。The above-mentioned embodiments are only preferred embodiments of the present invention, rather than all possible embodiments of the present invention. For those skilled in the art, any obvious changes made to it without departing from the principle and spirit of the present invention should be considered to be included in the protection scope of the claims of the present invention.

Claims (4)

1. A5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound characterized by having a structure of the general formula (d):
Figure FDA0002680682540000011
wherein X is CH3、H、F、Cl、Br、I。
2. The method for synthesizing a 5-substituted-2, 4-dithio-2 ', 3' -O-di-t-butyldimethylsilyl nucleoside compound according to claim 1, wherein the synthesizing step is: under the protection of nitrogen, reacting the 5-substituted deoxynucleoside compound with tert-butyldimethylsilyl chloride, and performing post-treatment after the reaction is finished to obtain a compound a; dissolving the compound a and 1,2, 4-triazole in an anhydrous acetonitrile solvent for reaction to obtain a light yellow solid b; finally, reacting the compound b with thioacetic acid in anhydrous acetonitrile to obtain a yellow solid compound c; finally, the compound c was stirred with lawson's reagent in anhydrous toluene at 80 ℃ overnight to give the final product d.
3. The method for synthesizing a 5-substituted-2, 4-dithio-2 ', 3' -O-di-t-butyldimethylsilyl nucleoside compound according to claim 2, wherein the synthesizing step is:
s1, synthesis of a compound a: under the protection of nitrogen, dissolving 5-substituted deoxynucleoside compound and imidazole in dichloromethane, stirring in ice-water bath, and adding tert-butyl dimethyl silicon chlorideAlkane, stirring for 1 hour at room temperature; after TLC detection reaction is finished, quenching with water and extracting with dichloromethane; the organic phases were combined, washed with saturated NaCl and anhydrous NaSO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain compound a as white solid, which is directly subjected to the next step S2 without purification;
s2, synthesis of a compound b: dissolving 1,2, 4-triazole in anhydrous acetonitrile, and slowly adding phosphorus oxychloride and triethylamine under the stirring of ice-water bath; after the reaction, 1 equivalent of the white solid compound a prepared in S1 was added and stirred at room temperature overnight; after TLC detection, the reaction solution was filtered, the organic phase was diluted with dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain a compound b which is a light yellow solid and is directly subjected to the next step S3 without purification;
s3, synthesis of a compound c: dissolving the compound b in anhydrous acetonitrile, adding 14 equivalents of thioacetic acid, and stirring at room temperature overnight; after TLC detection reaction is finished, the reaction solution is diluted by dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, decompressing and distilling off the solvent to obtain yellow solid, and separating and purifying by a silica gel column to obtain a compound c;
s4, synthesis of a compound d: 1 equivalent of compound c was dissolved in anhydrous toluene, added with Lawson's reagent and stirred at 80 ℃ overnight. And (5) separating and purifying by a silica gel column to obtain a compound d as a yellow solid.
4. The method for synthesizing a 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldimethylsilyl nucleoside compound according to claim 3, wherein the synthesizing step is specifically:
s1, synthesis of a compound a: under the protection of nitrogen, 1 equivalent of 5-substituted deoxynucleoside compound and 3 equivalents of imidazole are dissolved in dichloromethane and stirred for 30 minutes in ice-water bath; after 30 minutes, adding 2.5 equivalents of tert-butyldimethylsilyl chloride into the reaction system, and stirring for 1 hour at room temperature; after TLC detection reaction is finished, quenching with water and extracting with dichloromethane;the organic phases were combined, washed with saturated NaCl and anhydrous NaSO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain compound a as white solid, which is directly subjected to the next step S2 without purification;
s2, synthesis of a compound b: dissolving 14 equivalents of 1,2, 4-triazole in anhydrous acetonitrile, and slowly adding phosphorus oxychloride and triethylamine under the stirring of ice-water bath; after 1 hour of reaction, 1 equivalent of the white solid compound a prepared in S1 was added and stirred at room temperature overnight; after TLC detection, the reaction solution was filtered, the organic phase was diluted with dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain a compound b which is a light yellow solid and is directly subjected to the next step S3 without purification;
s3, synthesis of a compound c: dissolving 1 equivalent of the compound b in anhydrous acetonitrile, adding 14 equivalents of thioacetic acid, and stirring at room temperature overnight; after TLC detection reaction is finished, the reaction solution is diluted by dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, decompressing and distilling off the solvent to obtain yellow solid, and separating and purifying by a silica gel column to obtain a compound c;
s4, synthesis of a compound d: 1 equivalent of compound c was dissolved in anhydrous toluene, 2 equivalents of lawson's reagent was added, and stirring was carried out overnight at 80 ℃. And (5) separating and purifying by a silica gel column to obtain a compound d as a yellow solid.
CN202010961405.7A 2020-09-14 2020-09-14 5-Substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and synthesis method Withdrawn CN111944000A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010961405.7A CN111944000A (en) 2020-09-14 2020-09-14 5-Substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and synthesis method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010961405.7A CN111944000A (en) 2020-09-14 2020-09-14 5-Substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and synthesis method

Publications (1)

Publication Number Publication Date
CN111944000A true CN111944000A (en) 2020-11-17

Family

ID=73356514

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010961405.7A Withdrawn CN111944000A (en) 2020-09-14 2020-09-14 5-Substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and synthesis method

Country Status (1)

Country Link
CN (1) CN111944000A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675389A (en) * 2011-03-08 2012-09-19 大连大学 5-iodine-4-sulfur-2'-deoxyuridine, and derivatives and synthetic method thereof
CN102718822A (en) * 2012-05-18 2012-10-10 大连大学 Synthetic method of 4-sulfur thymidine and analogues of 4-sulfur thymidine under microwave irradiation
CN110105416A (en) * 2019-06-17 2019-08-09 大连大学 A kind of 4-S-5-Br-2 ', 3 ', 5 '-O- triacetyl uridine synthetic methods
CN110204584A (en) * 2019-06-17 2019-09-06 大连大学 A kind of 4-S-2 ', 3 ', 5 '-O- triacetyl uridine synthetic methods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675389A (en) * 2011-03-08 2012-09-19 大连大学 5-iodine-4-sulfur-2'-deoxyuridine, and derivatives and synthetic method thereof
CN102718822A (en) * 2012-05-18 2012-10-10 大连大学 Synthetic method of 4-sulfur thymidine and analogues of 4-sulfur thymidine under microwave irradiation
CN110105416A (en) * 2019-06-17 2019-08-09 大连大学 A kind of 4-S-5-Br-2 ', 3 ', 5 '-O- triacetyl uridine synthetic methods
CN110204584A (en) * 2019-06-17 2019-09-06 大连大学 A kind of 4-S-2 ', 3 ', 5 '-O- triacetyl uridine synthetic methods

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
PETER C. TLATELPA等: "Stability of pyrimidine N-glycosydic bonds in the presence of Lawesson’s reagents: revisit of 2-thiolation of pyrimidine nucleosides", 《TETRAHEDRON LETTERS》 *
WING L. SUNG: "Chemical Conversion of Uridine into 4-Thiouridine via the 4-(1,2,4-Triazol-l -yl)pyrimidin-2(1 H)-one Intermediate", 《J. CHEM. SOC., CHEM. COMMUN.》 *
YAO-ZHONG XU等: "Simple Synthesis of 4-Thiothymidine, 4-Thiouridine and 6-Thio-2’-deoxyguanosine", 《TETRAHEDRON LETTERS》 *
银鸿雁 等: "荧光素标记5-溴-4-硫-2′-脱氧尿苷合成及荧光光谱研究", 《分子科学学报》 *

Similar Documents

Publication Publication Date Title
EP2872485B1 (en) Asymmetric auxiliary group
EP0241363B1 (en) Nucleoside derivatives and their use in the synthesis of oligonucleotides
MXPA92005623A (en) Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use.
CN107108676A (en) Method for preparing the pure phosphoramidate prodrug of diastereo-isomerism
CN102675389B (en) 5-iodo-4-thio-2'-deoxyuridine and its derivatives and their synthesis method
CN101307084A (en) Synthetic process of Decitabine
CN115746073A (en) Diastereoselective synthesis of phosphate derivatives and gemcitabine prodrug NUC-1031
CN101967105A (en) Beta-hydroxy protected didecyl quaternary ammonium salt with anticancer activity and preparation method thereof
CN102718822A (en) Synthetic method of 4-sulfur thymidine and analogues of 4-sulfur thymidine under microwave irradiation
CN113061111A (en) Method for preparing amino acid compound with photocrosslinking activity
JP2000514404A (en) Nucleoside derivatives having photolabile protecting groups
WO2014109256A1 (en) Triazole-linked cyclic dinucleotide analogue
Colacino et al. Simple and efficient routes for the preparation of isoxazolidinyl nucleosides containing cytosine and 5-methyl-cytosine as new potential anti-HIV drugs
CN111944000A (en) 5-Substituted-2,4-dithio-2',3'-O-di-tert-butyldisilyl nucleoside compound and synthesis method
CN117624266A (en) Liver targeting compound, oligonucleotide conjugate thereof, coupling method and application
CN112175032B (en) Rapid synthesis of 5-substituted-4-thio-2',3'-O-di-tert-butyldisilyldeoxynucleoside compounds
US6750335B2 (en) Nucleoside derivatives with photolabile protective groups
이봉훈 et al. Partition Property of 5-Nitrothuopyrimidine Nucleoside
JPH01128996A (en) Nucleotide derivative, especially, 2'-deoxycitidine and its use in synthesis of oligonucleotide
CN105732758B (en) Cholic acid α aminophosphonate ester derivatives and its synthetic method
CN113563401A (en) Novel cordycepin alkanamide derivative and preparation method and application thereof
CN111808156A (en) Beta-nicotinamide riboside chloride crystal form 1A and crystal form 1B and preparation method thereof
CN106336443B (en) The synthetic method of a kind of nucleoside compound
CN112225760B (en) Synthesis method of 5-substituted-4-thio-2',3',5'-O-tri-tert-butyldisilyl nucleoside compound
EP0121635A1 (en) 3',5',-Diarabinosides, their preparation and their therapeutical application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20201117

WW01 Invention patent application withdrawn after publication